Glax­o­SmithK­line’s Hal Bar­ron poach­es Genen­tech’s top can­cer drug deal­mak­er for his new R&D team

Any­one look­ing for fresh hints about GSK’s up­com­ing move on the can­cer front needs to check out the phar­ma gi­ant’s lat­est hire.

New GSK R&D chief Hal Bar­ron has re­cruit­ed Kevin Sin, the long­time on­col­o­gy BD chief at Genen­tech, to the top job on the deal side of the com­pa­ny. His new of­fi­cial ti­tle is head of world­wide busi­ness de­vel­op­ment. And he’ll be mov­ing in­to Bar­ron’s new of­fice be­ing set up in San Fran­cis­co.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER